APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Enzalutamide Soft Capsules

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Enzalutamide Soft Capsules Market Analysis and Forecast 2026-2032

Report ID 173988590227 December 2025198 pages

Choose your research edition.

Industry ResearchEnzalutamide Soft Capsules Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Enzalutamide Soft Capsules Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Enzalutamide Soft Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Enzalutamide Soft Capsules Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Enzalutamide Soft Capsules Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Enzalutamide Soft Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Enzalutamide Soft Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Enzalutamide Soft Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Enzalutamide Soft Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Enzalutamide Soft Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Enzalutamide Soft Capsules include Aprazer Healthcare Pharma, Arechar Healthcare, Astellas Pharma, BDR Pharma, Glenmark Pharma, Intas Pharmaceuticals, Pfizer, Jiangsu Hansoh Pharmaceutical and Kelun Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Enzalutamide Soft Capsules, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Enzalutamide Soft Capsules, also provides the sales of main regions and countries. Of the upcoming market potential for Enzalutamide Soft Capsules, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Enzalutamide Soft Capsules sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Enzalutamide Soft Capsules market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Enzalutamide Soft Capsules sales, projected growth trends, production technology, application and end-user industry.

Enzalutamide Soft Capsules Segment by Company

Aprazer Healthcare Pharma

Arechar Healthcare

Astellas Pharma

BDR Pharma

Glenmark Pharma

Intas Pharmaceuticals

Pfizer

Jiangsu Hansoh Pharmaceutical

Kelun Pharmaceutical

Qilu Pharmaceutical

PuraCap Pharmaceuticals

Shenyang Hongqi Pharmaceutical

Yichang Humanwell Pharmaceutical

Enzalutamide Soft Capsules Segment by Type

Original Drug

Generic Drug

Enzalutamide Soft Capsules Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Enzalutamide Soft Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enzalutamide Soft Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enzalutamide Soft Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enzalutamide Soft Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Enzalutamide Soft Capsules in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Enzalutamide Soft Capsules manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Enzalutamide Soft Capsules sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Enzalutamide Soft Capsules Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Original Drug Major Manufacturers Table 3. Generic Drug Major Manufacturers Table 4. Global Enzalutamide Soft Capsules Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital and Clinic Major Manufacturers Table 6. Retail Pharmacies Major Manufacturers Table 7. Other Major Manufacturers Table 8. Enzalutamide Soft Capsules Industry Trends Table 9. Enzalutamide Soft Capsules Industry Drivers Table 10. Enzalutamide Soft Capsules Industry Opportunities and Challenges Table 11. Enzalutamide Soft Capsules Industry Restraints Table 12. Global Enzalutamide Soft Capsules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Enzalutamide Soft Capsules Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Enzalutamide Soft Capsules Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Enzalutamide Soft Capsules Revenue Market Share by Region (2021-2026) Table 16. Global Enzalutamide Soft Capsules Revenue Market Share by Region (2027-2032) Table 17. Global Enzalutamide Soft Capsules Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Enzalutamide Soft Capsules Sales by Region (2021-2026) & (K Units) Table 19. Global Enzalutamide Soft Capsules Sales by Region (2027-2032) & (K Units) Table 20. Global Enzalutamide Soft Capsules Sales Market Share by Region (2021-2026) Table 21. Global Enzalutamide Soft Capsules Sales Market Share by Region (2027-2032) Table 22. Global Enzalutamide Soft Capsules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Enzalutamide Soft Capsules Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Enzalutamide Soft Capsules Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Enzalutamide Soft Capsules Sales Market Share by Manufacturers (2021-2026) Table 26. Global Enzalutamide Soft Capsules Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Enzalutamide Soft Capsules Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Enzalutamide Soft Capsules Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Enzalutamide Soft Capsules Manufacturers, Product Type & Application Table 30. Global Enzalutamide Soft Capsules Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Enzalutamide Soft Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Enzalutamide Soft Capsules Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Enzalutamide Soft Capsules Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Enzalutamide Soft Capsules Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Enzalutamide Soft Capsules Revenue Market Share by Type (2021-2026) Table 37. Global Enzalutamide Soft Capsules Revenue Market Share by Type (2027-2032) Table 38. Global Enzalutamide Soft Capsules Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Enzalutamide Soft Capsules Sales by Type (2021-2026) & (K Units) Table 40. Global Enzalutamide Soft Capsules Sales by Type (2027-2032) & (K Units) Table 41. Global Enzalutamide Soft Capsules Sales Market Share by Type (2021-2026) Table 42. Global Enzalutamide Soft Capsules Sales Market Share by Type (2027-2032) Table 43. Global Enzalutamide Soft Capsules Price by Type (2021-2026) & (US$/Unit) Table 44. Global Enzalutamide Soft Capsules Price by Type (2027-2032) & (US$/Unit) Table 45. Global Enzalutamide Soft Capsules Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Enzalutamide Soft Capsules Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Enzalutamide Soft Capsules Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Enzalutamide Soft Capsules Revenue Market Share by Application (2021-2026) Table 49. Global Enzalutamide Soft Capsules Revenue Market Share by Application (2027-2032) Table 50. Global Enzalutamide Soft Capsules Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Enzalutamide Soft Capsules Sales by Application (2021-2026) & (K Units) Table 52. Global Enzalutamide Soft Capsules Sales by Application (2027-2032) & (K Units) Table 53. Global Enzalutamide Soft Capsules Sales Market Share by Application (2021-2026) Table 54. Global Enzalutamide Soft Capsules Sales Market Share by Application (2027-2032) Table 55. Global Enzalutamide Soft Capsules Price by Application (2021-2026) & (US$/Unit) Table 56. Global Enzalutamide Soft Capsules Price by Application (2027-2032) & (US$/Unit) Table 57. Aprazer Healthcare Pharma Company Information Table 58. Aprazer Healthcare Pharma Business Overview Table 59. Aprazer Healthcare Pharma Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Aprazer Healthcare Pharma Enzalutamide Soft Capsules Product Portfolio Table 61. Aprazer Healthcare Pharma Recent Development Table 62. Arechar Healthcare Company Information Table 63. Arechar Healthcare Business Overview Table 64. Arechar Healthcare Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Arechar Healthcare Enzalutamide Soft Capsules Product Portfolio Table 66. Arechar Healthcare Recent Development Table 67. Astellas Pharma Company Information Table 68. Astellas Pharma Business Overview Table 69. Astellas Pharma Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Astellas Pharma Enzalutamide Soft Capsules Product Portfolio Table 71. Astellas Pharma Recent Development Table 72. BDR Pharma Company Information Table 73. BDR Pharma Business Overview Table 74. BDR Pharma Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. BDR Pharma Enzalutamide Soft Capsules Product Portfolio Table 76. BDR Pharma Recent Development Table 77. Glenmark Pharma Company Information Table 78. Glenmark Pharma Business Overview Table 79. Glenmark Pharma Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Glenmark Pharma Enzalutamide Soft Capsules Product Portfolio Table 81. Glenmark Pharma Recent Development Table 82. Intas Pharmaceuticals Company Information Table 83. Intas Pharmaceuticals Business Overview Table 84. Intas Pharmaceuticals Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Intas Pharmaceuticals Enzalutamide Soft Capsules Product Portfolio Table 86. Intas Pharmaceuticals Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Pfizer Enzalutamide Soft Capsules Product Portfolio Table 91. Pfizer Recent Development Table 92. Jiangsu Hansoh Pharmaceutical Company Information Table 93. Jiangsu Hansoh Pharmaceutical Business Overview Table 94. Jiangsu Hansoh Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Jiangsu Hansoh Pharmaceutical Enzalutamide Soft Capsules Product Portfolio Table 96. Jiangsu Hansoh Pharmaceutical Recent Development Table 97. Kelun Pharmaceutical Company Information Table 98. Kelun Pharmaceutical Business Overview Table 99. Kelun Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Kelun Pharmaceutical Enzalutamide Soft Capsules Product Portfolio Table 101. Kelun Pharmaceutical Recent Development Table 102. Qilu Pharmaceutical Company Information Table 103. Qilu Pharmaceutical Business Overview Table 104. Qilu Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Qilu Pharmaceutical Enzalutamide Soft Capsules Product Portfolio Table 106. Qilu Pharmaceutical Recent Development Table 107. PuraCap Pharmaceuticals Company Information Table 108. PuraCap Pharmaceuticals Business Overview Table 109. PuraCap Pharmaceuticals Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. PuraCap Pharmaceuticals Enzalutamide Soft Capsules Product Portfolio Table 111. PuraCap Pharmaceuticals Recent Development Table 112. Shenyang Hongqi Pharmaceutical Company Information Table 113. Shenyang Hongqi Pharmaceutical Business Overview Table 114. Shenyang Hongqi Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Shenyang Hongqi Pharmaceutical Enzalutamide Soft Capsules Product Portfolio Table 116. Shenyang Hongqi Pharmaceutical Recent Development Table 117. Yichang Humanwell Pharmaceutical Company Information Table 118. Yichang Humanwell Pharmaceutical Business Overview Table 119. Yichang Humanwell Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Yichang Humanwell Pharmaceutical Enzalutamide Soft Capsules Product Portfolio Table 121. Yichang Humanwell Pharmaceutical Recent Development Table 122. North America Enzalutamide Soft Capsules Revenue by Type (2021-2026) & (US$ Million) Table 123. North America Enzalutamide Soft Capsules Revenue by Type (2027-2032) & (US$ Million) Table 124. North America Enzalutamide Soft Capsules Sales by Type (2021-2026) & (K Units) Table 125. North America Enzalutamide Soft Capsules Sales by Type (2027-2032) & (K Units) Table 126. North America Enzalutamide Soft Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 127. North America Enzalutamide Soft Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 128. North America Enzalutamide Soft Capsules Revenue by Application (2021-2026) & (US$ Million) Table 129. North America Enzalutamide Soft Capsules Revenue by Application (2027-2032) & (US$ Million) Table 130. North America Enzalutamide Soft Capsules Sales by Application (2021-2026) & (K Units) Table 131. North America Enzalutamide Soft Capsules Sales by Application (2027-2032) & (K Units) Table 132. North America Enzalutamide Soft Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 133. North America Enzalutamide Soft Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 134. North America Enzalutamide Soft Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. North America Enzalutamide Soft Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 136. North America Enzalutamide Soft Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 137. North America Enzalutamide Soft Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 138. North America Enzalutamide Soft Capsules Sales by Country (2021-2026) & (K Units) Table 139. North America Enzalutamide Soft Capsules Sales by Country (2027-2032) & (K Units) Table 140. North America Enzalutamide Soft Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 141. North America Enzalutamide Soft Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 142. United States Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 143. Canada Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 144. Mexico Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 145. Europe Enzalutamide Soft Capsules Revenue by Type (2021-2026) & (US$ Million) Table 146. Europe Enzalutamide Soft Capsules Revenue by Type (2027-2032) & (US$ Million) Table 147. Europe Enzalutamide Soft Capsules Sales by Type (2021-2026) & (K Units) Table 148. Europe Enzalutamide Soft Capsules Sales by Type (2027-2032) & (K Units) Table 149. Europe Enzalutamide Soft Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 150. Europe Enzalutamide Soft Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 151. Europe Enzalutamide Soft Capsules Revenue by Application (2021-2026) & (US$ Million) Table 152. Europe Enzalutamide Soft Capsules Revenue by Application (2027-2032) & (US$ Million) Table 153. Europe Enzalutamide Soft Capsules Sales by Application (2021-2026) & (K Units) Table 154. Europe Enzalutamide Soft Capsules Sales by Application (2027-2032) & (K Units) Table 155. Europe Enzalutamide Soft Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 156. Europe Enzalutamide Soft Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 157. Europe Enzalutamide Soft Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. Europe Enzalutamide Soft Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 159. Europe Enzalutamide Soft Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 160. Europe Enzalutamide Soft Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 161. Europe Enzalutamide Soft Capsules Sales by Country (2021-2026) & (K Units) Table 162. Europe Enzalutamide Soft Capsules Sales by Country (2027-2032) & (K Units) Table 163. Europe Enzalutamide Soft Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 164. Europe Enzalutamide Soft Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 165. Germany Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 166. France Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 167. U.K. Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 168. Italy Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 169. Russia Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 170. Spain Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 171. Netherlands Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 172. Switzerland Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 173. Sweden Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 174. Poland Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 175. China Enzalutamide Soft Capsules Revenue by Type (2021-2026) & (US$ Million) Table 176. China Enzalutamide Soft Capsules Revenue by Type (2027-2032) & (US$ Million) Table 177. China Enzalutamide Soft Capsules Sales by Type (2021-2026) & (K Units) Table 178. China Enzalutamide Soft Capsules Sales by Type (2027-2032) & (K Units) Table 179. China Enzalutamide Soft Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 180. China Enzalutamide Soft Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 181. China Enzalutamide Soft Capsules Revenue by Application (2021-2026) & (US$ Million) Table 182. China Enzalutamide Soft Capsules Revenue by Application (2027-2032) & (US$ Million) Table 183. China Enzalutamide Soft Capsules Sales by Application (2021-2026) & (K Units) Table 184. China Enzalutamide Soft Capsules Sales by Application (2027-2032) & (K Units) Table 185. China Enzalutamide Soft Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 186. China Enzalutamide Soft Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 187. Asia Enzalutamide Soft Capsules Revenue by Type (2021-2026) & (US$ Million) Table 188. Asia Enzalutamide Soft Capsules Revenue by Type (2027-2032) & (US$ Million) Table 189. Asia Enzalutamide Soft Capsules Sales by Type (2021-2026) & (K Units) Table 190. Asia Enzalutamide Soft Capsules Sales by Type (2027-2032) & (K Units) Table 191. Asia Enzalutamide Soft Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 192. Asia Enzalutamide Soft Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 193. Asia Enzalutamide Soft Capsules Revenue by Application (2021-2026) & (US$ Million) Table 194. Asia Enzalutamide Soft Capsules Revenue by Application (2027-2032) & (US$ Million) Table 195. Asia Enzalutamide Soft Capsules Sales by Application (2021-2026) & (K Units) Table 196. Asia Enzalutamide Soft Capsules Sales by Application (2027-2032) & (K Units) Table 197. Asia Enzalutamide Soft Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 198. Asia Enzalutamide Soft Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 199. Asia Enzalutamide Soft Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 200. Asia Enzalutamide Soft Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 201. Asia Enzalutamide Soft Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 202. Asia Enzalutamide Soft Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 203. Asia Enzalutamide Soft Capsules Sales by Country (2021-2026) & (K Units) Table 204. Asia Enzalutamide Soft Capsules Sales by Country (2027-2032) & (K Units) Table 205. Asia Enzalutamide Soft Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 206. Asia Enzalutamide Soft Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 207. Japan Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 208. South Korea Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 209. India Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 210. Australia Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 211. Taiwan Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 212. Southeast Asia Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 213. SAMEA Enzalutamide Soft Capsules Revenue by Type (2021-2026) & (US$ Million) Table 214. SAMEA Enzalutamide Soft Capsules Revenue by Type (2027-2032) & (US$ Million) Table 215. SAMEA Enzalutamide Soft Capsules Sales by Type (2021-2026) & (K Units) Table 216. SAMEA Enzalutamide Soft Capsules Sales by Type (2027-2032) & (K Units) Table 217. SAMEA Enzalutamide Soft Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 218. SAMEA Enzalutamide Soft Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 219. SAMEA Enzalutamide Soft Capsules Revenue by Application (2021-2026) & (US$ Million) Table 220. SAMEA Enzalutamide Soft Capsules Revenue by Application (2027-2032) & (US$ Million) Table 221. SAMEA Enzalutamide Soft Capsules Sales by Application (2021-2026) & (K Units) Table 222. SAMEA Enzalutamide Soft Capsules Sales by Application (2027-2032) & (K Units) Table 223. SAMEA Enzalutamide Soft Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 224. SAMEA Enzalutamide Soft Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 225. SAMEA Enzalutamide Soft Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 226. SAMEA Enzalutamide Soft Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 227. SAMEA Enzalutamide Soft Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 228. SAMEA Enzalutamide Soft Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 229. SAMEA Enzalutamide Soft Capsules Sales by Country (2021-2026) & (K Units) Table 230. SAMEA Enzalutamide Soft Capsules Sales by Country (2027-2032) & (K Units) Table 231. SAMEA Enzalutamide Soft Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 232. SAMEA Enzalutamide Soft Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 233. Brazil Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 234. Argentina Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 235. Chile Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 236. Colombia Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 237. Peru Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 238. Saudi Arabia Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 239. Israel Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 240. UAE Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 241. Turkey Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 242. Iran Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 243. Egypt Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Table 244. Key Raw Materials Table 245. Raw Materials Key Suppliers Table 246. Enzalutamide Soft Capsules Distributors List Table 247. Enzalutamide Soft Capsules Customers List Table 248. Research Programs/Design for This Report Table 249. Authors List of This Report Table 250. Secondary Sources Table 251. Primary Sources List of Figures Figure 1. Enzalutamide Soft Capsules Image Figure 2. Global Enzalutamide Soft Capsules Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Enzalutamide Soft Capsules Market Size Share 2021 VS 2025 VS 2032 Figure 4. Original Drug Image Figure 5. Generic Drug Image Figure 6. Global Enzalutamide Soft Capsules Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Enzalutamide Soft Capsules Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital and Clinic Image Figure 9. Retail Pharmacies Image Figure 10. Other Image Figure 11. Global Enzalutamide Soft Capsules Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Figure 13. Global Enzalutamide Soft Capsules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Enzalutamide Soft Capsules Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Enzalutamide Soft Capsules Revenue Market Share by Region (2021-2032) Figure 16. Global Enzalutamide Soft Capsules Sales (2021-2032) & (K Units) Figure 17. Global Enzalutamide Soft Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Enzalutamide Soft Capsules Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Enzalutamide Soft Capsules Sales YoY (2021-2032) & (K Units) Figure 20. Europe Enzalutamide Soft Capsules Sales YoY (2021-2032) & (K Units) Figure 21. China Enzalutamide Soft Capsules Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Enzalutamide Soft Capsules Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Enzalutamide Soft Capsules Sales YoY (2021-2032) & (K Units) Figure 24. Global Enzalutamide Soft Capsules Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Enzalutamide Soft Capsules Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Enzalutamide Soft Capsules Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Enzalutamide Soft Capsules Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Enzalutamide Soft Capsules Revenue Market Share by Type (2021-2032) Figure 30. Global Enzalutamide Soft Capsules Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Enzalutamide Soft Capsules Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Enzalutamide Soft Capsules Sales Market Share by Type (2021-2032) Figure 33. Global Enzalutamide Soft Capsules Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Enzalutamide Soft Capsules Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Enzalutamide Soft Capsules Revenue Market Share by Application (2021-2032) Figure 36. Global Enzalutamide Soft Capsules Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Enzalutamide Soft Capsules Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Enzalutamide Soft Capsules Sales Market Share by Application (2021-2032) Figure 39. North America Enzalutamide Soft Capsules Revenue Share by Type (2021-2032) Figure 40. North America Enzalutamide Soft Capsules Sales Share by Type (2021-2032) Figure 41. North America Enzalutamide Soft Capsules Revenue Share by Application (2021-2032) Figure 42. North America Enzalutamide Soft Capsules Sales Share by Application (2021-2032) Figure 43. North America Enzalutamide Soft Capsules Revenue Share by Country (2021-2032) Figure 44. North America Enzalutamide Soft Capsules Sales Share by Country (2021-2032) Figure 45. Europe Enzalutamide Soft Capsules Revenue Share by Type (2021-2032) Figure 46. Europe Enzalutamide Soft Capsules Sales Share by Type (2021-2032) Figure 47. Europe Enzalutamide Soft Capsules Revenue Share by Application (2021-2032) Figure 48. Europe Enzalutamide Soft Capsules Sales Share by Application (2021-2032) Figure 49. Europe Enzalutamide Soft Capsules Revenue Share by Country (2021-2032) Figure 50. Europe Enzalutamide Soft Capsules Sales Share by Country (2021-2032) Figure 51. China Enzalutamide Soft Capsules Revenue Share by Type (2021-2032) Figure 52. China Enzalutamide Soft Capsules Sales Share by Type (2021-2032) Figure 53. China Enzalutamide Soft Capsules Revenue Share by Application (2021-2032) Figure 54. China Enzalutamide Soft Capsules Sales Share by Application (2021-2032) Figure 55. Asia Enzalutamide Soft Capsules Revenue Share by Type (2021-2032) Figure 56. Asia Enzalutamide Soft Capsules Sales Share by Type (2021-2032) Figure 57. Asia Enzalutamide Soft Capsules Revenue Share by Application (2021-2032) Figure 58. Asia Enzalutamide Soft Capsules Sales Share by Application (2021-2032) Figure 59. Asia Enzalutamide Soft Capsules Revenue Share by Country (2021-2032) Figure 60. Asia Enzalutamide Soft Capsules Sales Share by Country (2021-2032) Figure 61. SAMEA Enzalutamide Soft Capsules Revenue Share by Type (2021-2032) Figure 62. SAMEA Enzalutamide Soft Capsules Sales Share by Type (2021-2032) Figure 63. SAMEA Enzalutamide Soft Capsules Revenue Share by Application (2021-2032) Figure 64. SAMEA Enzalutamide Soft Capsules Sales Share by Application (2021-2032) Figure 65. SAMEA Enzalutamide Soft Capsules Revenue Share by Country (2021-2032) Figure 66. SAMEA Enzalutamide Soft Capsules Sales Share by Country (2021-2032) Figure 67. Enzalutamide Soft Capsules Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Enzalutamide Soft Capsules Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Aprazer Healthcare Pharma
  • Arechar Healthcare
  • Astellas Pharma
  • BDR Pharma
  • Glenmark Pharma
  • Intas Pharmaceuticals
  • Pfizer
  • Jiangsu Hansoh Pharmaceutical
  • Kelun Pharmaceutical
  • Qilu Pharmaceutical
  • PuraCap Pharmaceuticals
  • Shenyang Hongqi Pharmaceutical
  • Yichang Humanwell Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Enzalutamide Soft Capsules Market by Type
  3. 1.2.1 Global Enzalutamide Soft Capsules Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Original Drug
  5. 1.2.3 Generic Drug
  6. 1.3 Enzalutamide Soft Capsules Market by Application
  7. 1.3.1 Global Enzalutamide Soft Capsules Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital and Clinic
  9. 1.3.3 Retail Pharmacies
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Enzalutamide Soft Capsules Market Dynamics
  1. 2.1 Enzalutamide Soft Capsules Industry Trends
  2. 2.2 Enzalutamide Soft Capsules Industry Drivers
  3. 2.3 Enzalutamide Soft Capsules Industry Opportunities and Challenges
  4. 2.4 Enzalutamide Soft Capsules Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Enzalutamide Soft Capsules Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Enzalutamide Soft Capsules Revenue by Region
  3. 3.2.1 Global Enzalutamide Soft Capsules Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Enzalutamide Soft Capsules Revenue by Region (2021-2026)
  5. 3.2.3 Global Enzalutamide Soft Capsules Revenue by Region (2027-2032)
  6. 3.2.4 Global Enzalutamide Soft Capsules Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Enzalutamide Soft Capsules Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Enzalutamide Soft Capsules Sales by Region
  9. 3.4.1 Global Enzalutamide Soft Capsules Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Enzalutamide Soft Capsules Sales by Region (2021-2026)
  11. 3.4.3 Global Enzalutamide Soft Capsules Sales by Region (2027-2032)
  12. 3.4.4 Global Enzalutamide Soft Capsules Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Enzalutamide Soft Capsules Revenue by Manufacturers
  2. 4.1.1 Global Enzalutamide Soft Capsules Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Enzalutamide Soft Capsules Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Enzalutamide Soft Capsules Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Enzalutamide Soft Capsules Sales by Manufacturers
  6. 4.2.1 Global Enzalutamide Soft Capsules Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Enzalutamide Soft Capsules Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Enzalutamide Soft Capsules Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Enzalutamide Soft Capsules Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Enzalutamide Soft Capsules Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Enzalutamide Soft Capsules Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Enzalutamide Soft Capsules Manufacturers, Product Type & Application
  13. 4.7 Global Enzalutamide Soft Capsules Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Enzalutamide Soft Capsules Market CR5 and HHI
  16. 4.8.2 2025 Enzalutamide Soft Capsules Tier 1, Tier 2, and Tier 3
5 Enzalutamide Soft Capsules Market by Type
  1. 5.1 Global Enzalutamide Soft Capsules Revenue by Type
  2. 5.1.1 Global Enzalutamide Soft Capsules Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Enzalutamide Soft Capsules Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Enzalutamide Soft Capsules Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Enzalutamide Soft Capsules Sales by Type
  6. 5.2.1 Global Enzalutamide Soft Capsules Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Enzalutamide Soft Capsules Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Enzalutamide Soft Capsules Sales Market Share by Type (2021-2032)
  9. 5.3 Global Enzalutamide Soft Capsules Price by Type
6 Enzalutamide Soft Capsules Market by Application
  1. 6.1 Global Enzalutamide Soft Capsules Revenue by Application
  2. 6.1.1 Global Enzalutamide Soft Capsules Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Enzalutamide Soft Capsules Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Enzalutamide Soft Capsules Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Enzalutamide Soft Capsules Sales by Application
  6. 6.2.1 Global Enzalutamide Soft Capsules Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Enzalutamide Soft Capsules Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Enzalutamide Soft Capsules Sales Market Share by Application (2021-2032)
  9. 6.3 Global Enzalutamide Soft Capsules Price by Application
7 Company Profiles
  1. 7.1 Aprazer Healthcare Pharma
  2. 7.1.1 Aprazer Healthcare Pharma Company Information
  3. 7.1.2 Aprazer Healthcare Pharma Business Overview
  4. 7.1.3 Aprazer Healthcare Pharma Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Aprazer Healthcare Pharma Enzalutamide Soft Capsules Product Portfolio
  6. 7.1.5 Aprazer Healthcare Pharma Recent Developments
  7. 7.2 Arechar Healthcare
  8. 7.2.1 Arechar Healthcare Company Information
  9. 7.2.2 Arechar Healthcare Business Overview
  10. 7.2.3 Arechar Healthcare Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Arechar Healthcare Enzalutamide Soft Capsules Product Portfolio
  12. 7.2.5 Arechar Healthcare Recent Developments
  13. 7.3 Astellas Pharma
  14. 7.3.1 Astellas Pharma Company Information
  15. 7.3.2 Astellas Pharma Business Overview
  16. 7.3.3 Astellas Pharma Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Astellas Pharma Enzalutamide Soft Capsules Product Portfolio
  18. 7.3.5 Astellas Pharma Recent Developments
  19. 7.4 BDR Pharma
  20. 7.4.1 BDR Pharma Company Information
  21. 7.4.2 BDR Pharma Business Overview
  22. 7.4.3 BDR Pharma Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 BDR Pharma Enzalutamide Soft Capsules Product Portfolio
  24. 7.4.5 BDR Pharma Recent Developments
  25. 7.5 Glenmark Pharma
  26. 7.5.1 Glenmark Pharma Company Information
  27. 7.5.2 Glenmark Pharma Business Overview
  28. 7.5.3 Glenmark Pharma Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Glenmark Pharma Enzalutamide Soft Capsules Product Portfolio
  30. 7.5.5 Glenmark Pharma Recent Developments
  31. 7.6 Intas Pharmaceuticals
  32. 7.6.1 Intas Pharmaceuticals Company Information
  33. 7.6.2 Intas Pharmaceuticals Business Overview
  34. 7.6.3 Intas Pharmaceuticals Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Intas Pharmaceuticals Enzalutamide Soft Capsules Product Portfolio
  36. 7.6.5 Intas Pharmaceuticals Recent Developments
  37. 7.7 Pfizer
  38. 7.7.1 Pfizer Company Information
  39. 7.7.2 Pfizer Business Overview
  40. 7.7.3 Pfizer Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Pfizer Enzalutamide Soft Capsules Product Portfolio
  42. 7.7.5 Pfizer Recent Developments
  43. 7.8 Jiangsu Hansoh Pharmaceutical
  44. 7.8.1 Jiangsu Hansoh Pharmaceutical Company Information
  45. 7.8.2 Jiangsu Hansoh Pharmaceutical Business Overview
  46. 7.8.3 Jiangsu Hansoh Pharmaceutical Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Jiangsu Hansoh Pharmaceutical Enzalutamide Soft Capsules Product Portfolio
  48. 7.8.5 Jiangsu Hansoh Pharmaceutical Recent Developments
  49. 7.9 Kelun Pharmaceutical
  50. 7.9.1 Kelun Pharmaceutical Company Information
  51. 7.9.2 Kelun Pharmaceutical Business Overview
  52. 7.9.3 Kelun Pharmaceutical Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Kelun Pharmaceutical Enzalutamide Soft Capsules Product Portfolio
  54. 7.9.5 Kelun Pharmaceutical Recent Developments
  55. 7.10 Qilu Pharmaceutical
  56. 7.10.1 Qilu Pharmaceutical Company Information
  57. 7.10.2 Qilu Pharmaceutical Business Overview
  58. 7.10.3 Qilu Pharmaceutical Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Qilu Pharmaceutical Enzalutamide Soft Capsules Product Portfolio
  60. 7.10.5 Qilu Pharmaceutical Recent Developments
  61. 7.11 PuraCap Pharmaceuticals
  62. 7.11.1 PuraCap Pharmaceuticals Company Information
  63. 7.11.2 PuraCap Pharmaceuticals Business Overview
  64. 7.11.3 PuraCap Pharmaceuticals Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 PuraCap Pharmaceuticals Enzalutamide Soft Capsules Product Portfolio
  66. 7.11.5 PuraCap Pharmaceuticals Recent Developments
  67. 7.12 Shenyang Hongqi Pharmaceutical
  68. 7.12.1 Shenyang Hongqi Pharmaceutical Company Information
  69. 7.12.2 Shenyang Hongqi Pharmaceutical Business Overview
  70. 7.12.3 Shenyang Hongqi Pharmaceutical Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Shenyang Hongqi Pharmaceutical Enzalutamide Soft Capsules Product Portfolio
  72. 7.12.5 Shenyang Hongqi Pharmaceutical Recent Developments
  73. 7.13 Yichang Humanwell Pharmaceutical
  74. 7.13.1 Yichang Humanwell Pharmaceutical Company Information
  75. 7.13.2 Yichang Humanwell Pharmaceutical Business Overview
  76. 7.13.3 Yichang Humanwell Pharmaceutical Enzalutamide Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Yichang Humanwell Pharmaceutical Enzalutamide Soft Capsules Product Portfolio
  78. 7.13.5 Yichang Humanwell Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Enzalutamide Soft Capsules Market Size by Type
  2. 8.1.1 North America Enzalutamide Soft Capsules Revenue by Type (2021-2032)
  3. 8.1.2 North America Enzalutamide Soft Capsules Sales by Type (2021-2032)
  4. 8.1.3 North America Enzalutamide Soft Capsules Price by Type (2021-2032)
  5. 8.2 North America Enzalutamide Soft Capsules Market Size by Application
  6. 8.2.1 North America Enzalutamide Soft Capsules Revenue by Application (2021-2032)
  7. 8.2.2 North America Enzalutamide Soft Capsules Sales by Application (2021-2032)
  8. 8.2.3 North America Enzalutamide Soft Capsules Price by Application (2021-2032)
  9. 8.3 North America Enzalutamide Soft Capsules Market Size by Country
  10. 8.3.1 North America Enzalutamide Soft Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Enzalutamide Soft Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Enzalutamide Soft Capsules Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Enzalutamide Soft Capsules Market Size by Type
  2. 9.1.1 Europe Enzalutamide Soft Capsules Revenue by Type (2021-2032)
  3. 9.1.2 Europe Enzalutamide Soft Capsules Sales by Type (2021-2032)
  4. 9.1.3 Europe Enzalutamide Soft Capsules Price by Type (2021-2032)
  5. 9.2 Europe Enzalutamide Soft Capsules Market Size by Application
  6. 9.2.1 Europe Enzalutamide Soft Capsules Revenue by Application (2021-2032)
  7. 9.2.2 Europe Enzalutamide Soft Capsules Sales by Application (2021-2032)
  8. 9.2.3 Europe Enzalutamide Soft Capsules Price by Application (2021-2032)
  9. 9.3 Europe Enzalutamide Soft Capsules Market Size by Country
  10. 9.3.1 Europe Enzalutamide Soft Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Enzalutamide Soft Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Enzalutamide Soft Capsules Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Enzalutamide Soft Capsules Market Size by Type
  2. 10.1.1 China Enzalutamide Soft Capsules Revenue by Type (2021-2032)
  3. 10.1.2 China Enzalutamide Soft Capsules Sales by Type (2021-2032)
  4. 10.1.3 China Enzalutamide Soft Capsules Price by Type (2021-2032)
  5. 10.2 China Enzalutamide Soft Capsules Market Size by Application
  6. 10.2.1 China Enzalutamide Soft Capsules Revenue by Application (2021-2032)
  7. 10.2.2 China Enzalutamide Soft Capsules Sales by Application (2021-2032)
  8. 10.2.3 China Enzalutamide Soft Capsules Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Enzalutamide Soft Capsules Market Size by Type
  2. 11.1.1 Asia Enzalutamide Soft Capsules Revenue by Type (2021-2032)
  3. 11.1.2 Asia Enzalutamide Soft Capsules Sales by Type (2021-2032)
  4. 11.1.3 Asia Enzalutamide Soft Capsules Price by Type (2021-2032)
  5. 11.2 Asia Enzalutamide Soft Capsules Market Size by Application
  6. 11.2.1 Asia Enzalutamide Soft Capsules Revenue by Application (2021-2032)
  7. 11.2.2 Asia Enzalutamide Soft Capsules Sales by Application (2021-2032)
  8. 11.2.3 Asia Enzalutamide Soft Capsules Price by Application (2021-2032)
  9. 11.3 Asia Enzalutamide Soft Capsules Market Size by Country
  10. 11.3.1 Asia Enzalutamide Soft Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Enzalutamide Soft Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Enzalutamide Soft Capsules Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Enzalutamide Soft Capsules Market Size by Type
  2. 12.1.1 SAMEA Enzalutamide Soft Capsules Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Enzalutamide Soft Capsules Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Enzalutamide Soft Capsules Price by Type (2021-2032)
  5. 12.2 SAMEA Enzalutamide Soft Capsules Market Size by Application
  6. 12.2.1 SAMEA Enzalutamide Soft Capsules Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Enzalutamide Soft Capsules Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Enzalutamide Soft Capsules Price by Application (2021-2032)
  9. 12.3 SAMEA Enzalutamide Soft Capsules Market Size by Country
  10. 12.3.1 SAMEA Enzalutamide Soft Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Enzalutamide Soft Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Enzalutamide Soft Capsules Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Enzalutamide Soft Capsules Value Chain Analysis
  2. 13.1.1 Enzalutamide Soft Capsules Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Enzalutamide Soft Capsules Production Mode & Process
  6. 13.2 Enzalutamide Soft Capsules Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Enzalutamide Soft Capsules Distributors
  9. 13.2.3 Enzalutamide Soft Capsules Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst